Chlamydia trachomatis control requires a vaccine.

  title={Chlamydia trachomatis control requires a vaccine.},
  author={R. Brunham and R. Rappuoli},
  volume={31 15},
  • R. Brunham, R. Rappuoli
  • Published 2013
  • Biology, Medicine
  • Vaccine
  • As the most common reported communicable disease in North America and Europe, Chlamydia trachomatis is the focus of concerted public health control efforts based on screening and treatment. Unexpectedly control efforts are accompanied by rising reinfection rates attributed in part to arresting the development of herd immunity. Shortening the duration of infection through the testing and treatment program is the root cause behind the arrested immunity hypothesis and because of this a vaccine… CONTINUE READING
    65 Citations

    Figures and Topics from this paper

    Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis
    • 15
    Update on Chlamydia trachomatis Vaccinology
    • 47
    • PDF
    Considerations for the rational design of a Chlamydia vaccine
    • 10
    Development of a vaccine for Chlamydia trachomatis : challenges and current progress
    • 6
    • PDF
    Genetic variation in Chlamydia trachomatis and their hosts: impact on disease severity and tissue tropism.
    • 49


    Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine
    • 545
    Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen.
    • 141
    • PDF
    The arrested immunity hypothesis and the epidemiology of chlamydia control.
    • 131
    Chlamydial vaccine development.
    • D. Longbottom
    • Biology, Medicine
    • Journal of medical microbiology
    • 2003
    • 34
    • PDF
    Role of T lymphocytes in the pathogenesis of Chlamydia disease.
    • 58
    • PDF